MKULQ — Molekule Balance Sheet
0.000.00%
- $0.01m
- $30.91m
- $0.23m
Annual balance sheet for Molekule, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.001 | 2.33 | 19.6 | 22.1 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0 | 0.101 | 0.177 | 0.036 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Current Assets | 0.001 | 2.74 | 21.6 | 24.8 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0 | 0.455 | 2.12 | 3.73 |
Net Goodwill | ||||
Other Long Term Assets | ||||
Total Assets | 0.001 | 3.19 | 23.7 | 29.2 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.231 | 0.665 | 1.51 | 4.56 |
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.231 | 0.665 | 2.01 | 9.46 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | -0.231 | 2.53 | 21.7 | 19.7 |
Total Liabilities & Shareholders' Equity | 0.001 | 3.19 | 23.7 | 29.2 |
Total Common Shares Outstanding |